scholarly journals Catheter-directed thrombolysis for acute deep vein thrombosis

The Lancet ◽  
2012 ◽  
Vol 379 (9828) ◽  
pp. 1785-1786
Author(s):  
Inge M van Schouwenburg ◽  
Hilde AM Kooistra ◽  
Nic JGM Veeger ◽  
Karina Meijer
Keyword(s):  
Deep Vein Thrombosis ◽  
Vein Thrombosis ◽  
Catheter Directed Thrombolysis ◽  
Acute Deep Vein Thrombosis ◽  
Deep Vein

Catheter-directed thrombolysis for acute deep vein thrombosis – Authors' reply

The Lancet ◽  
2012 ◽  
Vol 379 (9828) ◽  
pp. 1786-1787
Author(s):  
Tone Enden ◽  
Nils-Einar Kløw ◽  
Per Morten Sandset
Keyword(s):  
Deep Vein Thrombosis ◽  
Vein Thrombosis ◽  
Catheter Directed Thrombolysis ◽  
Acute Deep Vein Thrombosis ◽  
Deep Vein

Endovascular management of extensive lower extremity acute deep vein thrombosis with AngioJet rheolytic thrombectomy plus catheter-directed thrombolysis from contralateral femoral access

2018 ◽  
Vol 34 (4) ◽  
pp. 257-265 ◽  
Author(s):  
Guang Liu ◽  
Zhen Zhao ◽  
Chaoyi Cui ◽  
Kaichuang Ye ◽  
Minyi Yin ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Femoral Access ◽  
Technical Success Rate ◽  
Vein Thrombosis ◽  
Catheter Directed Thrombolysis ◽  
Rheolytic Thrombectomy ◽  
Complete Lysis ◽  
Acute Deep Vein Thrombosis ◽  
Deep Vein

Purpose The aim of the present study was to report the clinical outcomes of endovascular treatment for extensive lower limb deep vein thrombosis with AngioJet rheolytic thrombectomy (ART) plus catheter-directed thrombolysis (CDT) using a contralateral femoral approach. Methods A retrospective analysis of consecutive ART+CDT treatments in 38 deep vein thrombosis patients (LET I-III, from September 2014 to March 2016) was performed. Results The technical success rate was 100%. Complete lysis was achieved in 82% of LET III segments (calf veins), 87% of LET II segments (popliteal-femoral veins), and 90% of LET III segments (iliac veins). The best results were obtained in patients treated within seven days of symptom onset. During follow-up, well-preserved, competent femoral valves were observed in 86% of the patients, and recanalization of LET III, LET II, and LET I segments was achieved in 100%, 94%, and 91% of the patients, respectively. The post-thrombotic syndrome rate was 17% during a mean 20-month follow-up.

Optimal diagnostics of residual stenosis after lysis

2016 ◽  
Vol 31 (1_suppl) ◽  
pp. 11-14
Author(s):  
Daniel Hagley ◽  
Prakash Saha ◽  
Stephen Black
Keyword(s):  
Deep Vein Thrombosis ◽  
Imaging Modality ◽  
Venous System ◽  
Residual Stenosis ◽  
Vein Thrombosis ◽  
The Past ◽  
Catheter Directed Thrombolysis ◽  
Detailed Assessment ◽  
Acute Deep Vein Thrombosis ◽  
Deep Vein

The treatment of acute deep vein thrombosis has developed significantly over the past few years, and catheter-directed thrombolysis is now widely accepted. Controversy still exists over the decision to treat residual or underlying lesions with a venous stent. Magnetic resonance techniques have evolved considerably, which together with intravenous ultrasound can provide a detailed assessment of the deep venous system. Nevertheless, there is still no single perfect imaging modality that can identify a functional stenosis in the venous system. The decision to proceed to stent placement following lysis is multifactorial, reliant on the use of a number of imaging modalities in combination but most importantly good clinical acumen and experience.

scholarly journals Evaluation of Catheter-Directed Thrombolysis for Acute Deep Vein Thrombosis

2005 ◽  
Vol 34 (6) ◽  
pp. 401-405 ◽  
Author(s):  
Tsutomu Hattori ◽  
Hideaki Maeda ◽  
Hisaki Umezawa ◽  
Masakazu Goshima ◽  
Tetsuya Nakamura ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Vein Thrombosis ◽  
Catheter Directed Thrombolysis ◽  
Acute Deep Vein Thrombosis ◽  
Deep Vein

Iliac vein stenting as a durable option for residual stenosis after catheter-directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to May–Thurner syndrome

2013 ◽  
Vol 29 (7) ◽  
pp. 461-470 ◽  
Author(s):  
Jae Young Park ◽  
Jong Hyuk Ahn ◽  
Yong Sun Jeon ◽  
Soon Gu Cho ◽  
Jang Yong Kim ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Patency Rate ◽  
Iliac Vein ◽  
Primary Patency ◽  
Primary Patency Rate ◽  
Vein Thrombosis ◽  
Catheter Directed Thrombolysis ◽  
Acute Deep Vein Thrombosis ◽  
Deep Vein

Introduction This study aims to evaluate the primary patency and clinical outcomes after stenting for residual iliac venous stenosis during catheter-directed thrombolysis treatment of acute iliofemoral deep vein thrombosis arising from May–Thurner syndome. Methods A retrospective study was done for the all patients who underwent iliac vein stenting after catheter-directed thrombolysis treatment of acute iliofemoral deep vein thrombosis due to May–Thurner syndrome from January 2005 to April 2011 in Inha University Hospital. Patient information was assembled from the electronic medical records, imaging and interview. The patency of iliac vein stent was evaluated with serial computed tomography. Results Fifty-one patients were enrolled. The median age was 70 years (range 44–86). There were 37 females (72.5%). The duration of symptoms of acute deep vein thrombosis before catheter-directed thrombolysis treatment was 6 days (median, range 1–33). Self-expanding stent was used for iliac vein stenting. Initial technical success rate was 94.1%. There were two complications (3.9%): an arteriovenous fistula formation in left popliteal area and a right inguinal hematoma. Mean follow-up was 15.6 months (range 6 days–80.8 months). Primary patency rate after iliac vein stenting was 95.8% at 6 months, 87.5% at 12 months and 84.3% at 24 months. Four patients had recurrent thrombotic occlusion (7.8%) during the follow-up. Conclusion Iliac vein stenting showed good primary patency rate with few complications. Iliac vein stenting is a durable option for residual stenosis after catheter-directed thrombolysis treatment of acute deep vein thrombosis in May–Thurner syndrome.

Sign in / Sign up

Export Citation Format

Share Document